InnoMed Capital

InnoMed Capital concentrates on the healthcare sector, targeting medical devices, diagnostics, and life sciences companies. The firm invests across early-stage venture and growth equity rounds, primarily within China. This specialized focus aligns with the significant government and private capital flowing into domestic healthcare innovation, particularly in Jiangsu province where the firm is based.

Current fundraising activity for InnoMed Capital has not been publicly disclosed in English-language financial media or regulatory filings. Private Chinese fund managers often raise capital on a rolling or project-specific basis, and absence of public reporting does not necessarily indicate dormancy.